No Benefit of EC/IC Bypass vs Meds in Large-Artery Stroke

Despite surgical advances, adding extracranial-intracranial bypass to medical therapy does not reduce stroke or death in symptomatic occlusion of the internal carotid or middle cerebral artery.

Related Keywords

Liqun ,Hainan ,China ,Beijing ,United States ,American ,Seemant Chaturvedi ,Thomas Jeerakathil ,J Marc Simard ,Journal Of The American Medical Association ,University Of Alberta ,University Of Maryland School Medicine ,National Center ,Stroke Strategic Clinical Network ,Alberta Health Services ,Neurological Disorders ,American Medical ,Carotid Occlusion Surgery Study ,Middle Cerebral Artery Occlusion Surgery Study ,Northern Stroke Lead ,Maryland School ,National Health Commission ,Stroke ,Erebrovascular Accident ,Va Cerebrovascular Accident ,Thromboembolism ,Neurosurgery ,Arteries ,Middle Cerebral Artery ,Ca Middle Cerebral Artery ,Surgery ,Hemodynamics ,Hemodynamic Monitoring ,Blood ,Ischemic Stroke ,Brain ,Stroke Risk ,Clinical Research ,Clinical Trials ,Linical Studies ,Cox ,Yclooxygenase ,Grant ,Maryland ,Perioperative ,Recurrent Stroke ,Transplant Evaluation ,Atient Selecti ,